Delivery Order SPE2DU25D9439-SPE2DU26FEEEL

The Defense Logistics Agency awarded a $15,340.52 firm fixed-price delivery order (4570185916) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (SPE2DR) established through the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. No set-aside designation was used for this award. The delivery order represents one of numerous purchase orders issued to DMS Pharmaceutical Group by the Defense Logistics Agency's Medical Supply Chain division to support recurring pharmaceutical supply needs for Department of Defense healthcare facilities.

DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to federal agencies, including branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals. The company's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals required by military healthcare operations. The broader PPV-G GEN V contract, valued at $499.999 billion with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor within the $30.3 billion federal pharmaceutical supply chain strategy, with demonstrated capability to fulfill diverse and specialized medical supply requirements across Department of Defense healthcare operations worldwide.